Market Overview:
The global eosinophilic asthma treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of asthma, increasing awareness about eosinophilic asthma, and technological advancements in the field of eosinophilic asthma treatment. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. The global eosinophilic asthma treatment market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into oral treatments, rectal treatments, intravenous treatments, and nasal treatments. and others including systemic corticosteroids).
Product Definition:
Eosinophilic asthma treatment is the use of medications and other treatments to try to control eosinophilic asthma.
Oral:
Oral drug delivery systems are used to deliver drugs to patients in remote areas where conventional methods of medication cannot be employed. The most commonly used oral route of medication is the administration of tablets, capsules and solutions. Other forms such as gels, creams and drops are also widely accepted by patients for treatment purposes.
Rectal:
rectal refers to the opening at the end of the digestive tract. It is also known as the anal opening orifice. Eosinophilic asthma is a type of chronic obstructive pulmonary disease (COPD) caused by eosinophils, a type of white blood cell that causes inflammation and contributes to asthma symptoms such as wheezing, chest tightness, and cough.
Application Insights:
Based on application, the global eosinophilic asthma treatment market is segmented into children, adults and teenagers. The children segment held the largest share in 2017 due to high prevalence of eosinophilic asthma among this age group. According to a study published by NCBI in 2018, around 40% of patients with eosinophilic asthma are under 5 years of age. In addition, another study conducted by WHO found that 54% out of total number of patients with allergic rhinitis were kids below 14 years old. These factors are anticipated to boost demand for effective and efficient medicines during the forecast period.
The adult segment is expected to witness fastest growth over forecast period owing to rising awareness about availability of effective treatments for eosinophilic asthma among this population group as well as increasing incidences reported from developing countries such as China and India where prevalence rate for allergic rhinitis is also comparatively higher than other regions globally (0-14 yrs).
Regional Analysis:
North America dominated the global eosinophilic asthma treatment market in 2017. This can be attributed to the presence of key pharmaceutical companies, increased awareness about eosinophilic disorders and availability of effective treatments for them. Moreover, increasing government initiatives and rising healthcare expenditure by governments are some other factors contributing to the growth of this regional market. For instance, in 2014, FDA approved Flovent (fluticasone propionate) inhaler for indoor & outdoor allergic rhinitis symptoms caused by tree pollen which is one of the most common causes for seasonal allergies among American population.
Growth Factors:
- Increasing prevalence of asthma: The global prevalence of asthma is increasing every year. This will lead to an increase in the demand for eosinophilic asthma treatment products.
- Growing awareness about eosinophilic asthma: There is a growing awareness among people about eosinophilic asthma and its symptoms. This will lead to an increase in the demand for eosinophilic asthma treatment products.
- Technological advancements in the field of eosinophilic asthma treatment: There have been several advancements in the field of technology related to diagnosis and treatment of eosinofilic asthma over the past few years. This will lead to an increase in demand for such treatments.
Scope Of The Report
Report Attributes
Report Details
Report Title
Eosinophilic Asthma Treatment Market Research Report
By Type
Oral, Rectal, Intravenous, Nasal
By Application
Children, Adults, Teenagers
By Companies
Johnson & Johnson, Novartis, Roche, Pfizer, Sanofi, Merck, GlaxoSmithKline, AstraZeneca, Bayer, Gilead
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Eosinophilic Asthma Treatment Market Report Segments:
The global Eosinophilic Asthma Treatment market is segmented on the basis of:
Types
Oral, Rectal, Intravenous, Nasal
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adults, Teenagers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Novartis
- Roche
- Pfizer
- Sanofi
- Merck
- GlaxoSmithKline
- AstraZeneca
- Bayer
- Gilead
Highlights of The Eosinophilic Asthma Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Rectal
- Intravenous
- Nasal
- By Application:
- Children
- Adults
- Teenagers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eosinophilic Asthma Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Eosinophilic asthma is a type of asthma that is characterized by an excessive number of eosinophils in the airways. Eosinophils are white blood cells that play a role in allergic reactions and inflammation. Treatment for eosinophilic asthma typically includes medications to control symptoms and prevent further damage to the lungs, as well as treatments to reduce the number of eosinophils in the airways.
Some of the major companies in the eosinophilic asthma treatment market are Johnson & Johnson, Novartis, Roche, Pfizer, Sanofi, Merck, GlaxoSmithKline, AstraZeneca, Bayer, Gilead.
The eosinophilic asthma treatment market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eosinophilic Asthma Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Eosinophilic Asthma Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Eosinophilic Asthma Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Eosinophilic Asthma Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Eosinophilic Asthma Treatment Market Size & Forecast, 2018-2028
4.5.1 Eosinophilic Asthma Treatment Market Size and Y-o-Y Growth
4.5.2 Eosinophilic Asthma Treatment Market Absolute $ Opportunity
Chapter 5 Global Eosinophilic Asthma Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Eosinophilic Asthma Treatment Market Size Forecast by Type
5.2.1 Oral
5.2.2 Rectal
5.2.3 Intravenous
5.2.4 Nasal
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Eosinophilic Asthma Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Eosinophilic Asthma Treatment Market Size Forecast by Applications
6.2.1 Children
6.2.2 Adults
6.2.3 Teenagers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Eosinophilic Asthma Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Eosinophilic Asthma Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Eosinophilic Asthma Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Eosinophilic Asthma Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Eosinophilic Asthma Treatment Market Size Forecast by Type
9.6.1 Oral
9.6.2 Rectal
9.6.3 Intravenous
9.6.4 Nasal
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Eosinophilic Asthma Treatment Market Size Forecast by Applications
9.10.1 Children
9.10.2 Adults
9.10.3 Teenagers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Eosinophilic Asthma Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Eosinophilic Asthma Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Eosinophilic Asthma Treatment Market Size Forecast by Type
10.6.1 Oral
10.6.2 Rectal
10.6.3 Intravenous
10.6.4 Nasal
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Eosinophilic Asthma Treatment Market Size Forecast by Applications
10.10.1 Children
10.10.2 Adults
10.10.3 Teenagers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Eosinophilic Asthma Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Eosinophilic Asthma Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Eosinophilic Asthma Treatment Market Size Forecast by Type
11.6.1 Oral
11.6.2 Rectal
11.6.3 Intravenous
11.6.4 Nasal
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Eosinophilic Asthma Treatment Market Size Forecast by Applications
11.10.1 Children
11.10.2 Adults
11.10.3 Teenagers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Eosinophilic Asthma Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Eosinophilic Asthma Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Eosinophilic Asthma Treatment Market Size Forecast by Type
12.6.1 Oral
12.6.2 Rectal
12.6.3 Intravenous
12.6.4 Nasal
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Eosinophilic Asthma Treatment Market Size Forecast by Applications
12.10.1 Children
12.10.2 Adults
12.10.3 Teenagers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Eosinophilic Asthma Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Eosinophilic Asthma Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Eosinophilic Asthma Treatment Market Size Forecast by Type
13.6.1 Oral
13.6.2 Rectal
13.6.3 Intravenous
13.6.4 Nasal
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Eosinophilic Asthma Treatment Market Size Forecast by Applications
13.10.1 Children
13.10.2 Adults
13.10.3 Teenagers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Eosinophilic Asthma Treatment Market: Competitive Dashboard
14.2 Global Eosinophilic Asthma Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Novartis
14.3.3 Roche
14.3.4 Pfizer
14.3.5 Sanofi
14.3.6 Merck
14.3.7 GlaxoSmithKline
14.3.8 AstraZeneca
14.3.9 Bayer
14.3.10 Gilead
